Company Filing History:
Years Active: 2024
Title: Miaomiao Wei: Innovator in Pharmaceutical Technology
Introduction
Miaomiao Wei is a prominent inventor based in Hebei, China. She has made significant contributions to the field of pharmaceutical technology, particularly in the development of innovative compounds for medical use. Her work focuses on addressing HIF-related and EPO-related diseases, showcasing her commitment to advancing healthcare solutions.
Latest Patents
Miaomiao Wei holds a patent for a compound known as a 1,7-naphthyridine derivative. This compound is represented by a specific formula and includes various forms such as tautomers, optical isomers, nitrogen oxides, solvates, and pharmaceutically acceptable salts or prodrugs. The patent outlines the preparation method for this compound and its application in drug compositions aimed at treating or alleviating conditions related to HIF and EPO in patients.
Career Highlights
Miaomiao Wei is associated with Cspc Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd., where she applies her expertise in pharmaceutical research and development. Her innovative approach has led to the creation of valuable therapeutic compounds that have the potential to improve patient outcomes.
Collaborations
Miaomiao Wei collaborates with talented colleagues, including Yan Zhang and Xuejiao Zhang. These partnerships enhance her research efforts and contribute to the advancement of pharmaceutical technologies.
Conclusion
Miaomiao Wei's contributions to the field of pharmaceutical technology exemplify her dedication to innovation and improving healthcare. Her patent for the 1,7-naphthyridine derivative highlights her role as a key inventor in developing solutions for critical medical conditions.